What 4 Analyst Ratings Have To Say About Cimpress
Analysts have provided the following ratings for Cimpress (NASDAQ:CMPR) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Earnings Scheduled For July 26, 2023
Companies Reporting Before The Bell
• GSK (NYSE:GSK) is estimated to report quarterly earnings at $0.87 per share on revenue of $8.97 billion.
• Stellantis (NYSE:STLA) is likely to report earnings for its first quarter.
Analyst Ratings for Cimpress
Within the last quarter, Cimpress (NASDAQ:CMPR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
Lennox International, Meta Platforms, Hasbro And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For April 26, 2023
Companies Reporting Before The Bell
• Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion.
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
$1M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $45
Truist Securities analyst Youssef Squali maintains Cimpress (NASDAQ:CMPR) with a Buy and lowers the price target from $85 to $45.
Cimpress Q2 Sales $845.20M Miss $901.00M Estimate
Cimpress (NASDAQ:CMPR) reported quarterly sales of $845.20 million which missed the analyst consensus estimate of $901.00 million by 6.19 percent. This is a 0.53 percent decrease over sales of $849.72 million the same